Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy. 

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

Powerful new therapy doubles progression-free survival in advanced breast cancer 30
Oct
2024

A three-drug combination for aggressive advanced breast cancer doubles the length of time before the cancer progresses, compared with a drug combination currently available on the NHS, new research has shown. Find out more

More than £5 million secured for the ICR from Cancer Research UK’s RadNet programme to fund work in radiotherapy 30
Oct
2024

Cancer Research UK (CRUK) has awarded The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust a substantial £5.14 million through its radiation research network (RadNet) to support pioneering research in radiation therapy. Find out more

New imaging technique could spot patients with aggressive brain tumours who would benefit from immunotherapy 24
Oct
2024

A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, according to researchers. Find out more

See all news articles

Features

Scientific achievements of 2023 05
Dec
2023

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more

Untapping the full potential of immunotherapies for more people with cancer 06
Jun
2023

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential. Find out more

Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care 14
Mar
2023

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it. Find out more

See all feature articles